Simplify Logo

Full-Time

Associate Director

Quality Assurance, Gcp

Updated on 9/13/2024

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Management
Quality Assurance (QA)
Requirements
  • Bachelor’s degree in a scientific field.
  • Minimum of 8 years of Quality Assurance/GCP/GCLP/GVP Operations experience in pharmaceutical or biotech industry.
  • In-depth knowledge of GCP/GCLP/GVP and QA principles, practices, and standards; thorough understanding of FDA, MHRA, EMA and ICH quality regulations.
Responsibilities
  • You will be the GCP Quality Lead to assigned studies/programs. Review all things GCP/GCLP/GVP; study protocols and manuals, clinical study reports, investigator brochures, informed consent forms, safety management plans, aggregate reports, etc.
  • You will create and execute risk-based clinical trial audit plans and participate in clinical vendor evaluation and qualification.
  • You will create and implement a GCP/GCLP/GVP inspection readiness strategy and plan in collaboration with your Clinical Development colleagues.
  • You will conduct/support internal audits and provide audit metrics, audit observations, and develop robust CAPAs for cross functional team and management review.
  • You will develop and execute Quality Agreements with applicable vendors.
  • You will interpret and manage quality investigations associated with GCP/GCLP/GVP operations.
  • You will be proactive, and you will effectively communicate with GCP/GCLP/GVP vendors to address and resolve complex and routine activities while building positive client/vendor relationships, fostering continuous improvement, and adding value to the Clinical Development team.
  • You will contribute to the continued development of the GCP/GCLP/GVP Quality Management Systems, conduct risk assessments and identify areas to be audited and potential process improvements.
  • You will be flexible and adaptable. You will eagerly contribute to the development of the Quality Management System even in aspects that extend beyond GCP/GCLP/GVP, including maintaining and reviewing metrics to monitor performance.
  • You will provide Quality Assurance subject matter expertise, leadership, and guidance to external CROs as well as in support of your Relay Clinical Development colleagues.
  • You will provide review of applicable GCP/GCLP/GVP documentation and regulatory submissions.
  • You will contribute significantly to other areas of Quality Assurance as needed as Relay’s Quality team grows and the QMS evolves.

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with traditional approaches. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options, especially in precision oncology and genetic diseases. Unlike its competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create impactful medicines for patients, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

-10%

2 year growth

-2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Relay's focus on precision oncology and genetic diseases positions it at the forefront of personalized medicine, offering significant growth potential.
  • Recent investments and financing, including a $30 million private placement and $400 million Series C financing, indicate strong financial backing and investor confidence.
  • Initial clinical data for RLY-2608 and other promising drug candidates highlight the company's potential for successful therapeutic developments.

What critics are saying

  • The highly competitive biotech sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and licensing agreements could pose risks if collaborations do not yield expected results.

What makes Relay Therapeutics unique

  • Relay Therapeutics places protein motion at the core of its drug discovery process, a unique approach that sets it apart from traditional methods.
  • The Dynamo™ platform combines experimental and computational techniques to target previously undruggable proteins, expanding treatment possibilities.
  • Strategic collaborations, such as the one with Genentech, validate the potential of Relay's innovative technology and approach.

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO